Discovery of novel sphingosine kinase-1 inhibitors. Part 2
摘要:
Building on our initial work, we have identified additional novel inhibitors of sphingosine kinase-1 (SK1). These new analogs address the shortcomings found in our previously reported compounds. Inhibitors 51 and 54 demonstrated oral bioavailability in a rat PK study. Published by Elsevier Ltd.
Discovery of novel sphingosine kinase-1 inhibitors. Part 2
摘要:
Building on our initial work, we have identified additional novel inhibitors of sphingosine kinase-1 (SK1). These new analogs address the shortcomings found in our previously reported compounds. Inhibitors 51 and 54 demonstrated oral bioavailability in a rat PK study. Published by Elsevier Ltd.
The invention relates to compounds of Formula (I). Compounds of the present invention are inhibitors of sphingosine kinase 3, and are useful in the treatment of various disorders and conditions, such as inflammatory disorders.
[EN] INHIBITORS OF SPHINGOSINE KINASE 1<br/>[FR] INHIBITEURS DE LA SPHINGOSINE KINASE 1
申请人:GENZYME CORP
公开号:WO2010033701A3
公开(公告)日:2016-03-24
Discovery of novel sphingosine kinase-1 inhibitors. Part 2
作者:Yibin Xiang、Bradford Hirth、John L. Kane、Junkai Liao、Kevin D. Noson、Christopher Yee、Gary Asmussen、Maria Fitzgerald、Christine Klaus、Michael Booker
DOI:10.1016/j.bmcl.2010.06.019
日期:2010.8
Building on our initial work, we have identified additional novel inhibitors of sphingosine kinase-1 (SK1). These new analogs address the shortcomings found in our previously reported compounds. Inhibitors 51 and 54 demonstrated oral bioavailability in a rat PK study. Published by Elsevier Ltd.